Document Detail


An alternative monitoring protocol for single-dose methotrexate therapy in ectopic pregnancy.
MedLine Citation:
PMID:  19962125     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: We sought to determine the sensitivity and specificity of alternative monitoring regimens in predicting the need for a second methotrexate (MTX) dose in women undergoing medical therapy for ectopic pregnancy. STUDY DESIGN: We reviewed 187 women who received MTX for ectopic pregnancy. RESULTS: We defined MTX treatment success as a clinically stable patient whose day-7 beta human chorionic gonadotropin (beta-hCG) level decreased by > or = 50%, compared with the day-of-treatment (DOT) beta-hCG. In comparison to the standard MTX monitoring protocol, this model was 100% sensitive and 57.4% specific in predicting the need for a second MTX dose in women whose DOT beta-hCG was <2000 mIU/mL and was 100% sensitive and 37.9% specific in women whose DOT beta-hCG was > or = 2000 mIU/mL. CONCLUSION: This model is an alternative to the traditional MTX monitoring regimen.
Authors:
Andrea Ries Thurman; Melani Cornelius; Jeffrey E Korte; Donald L Fylstra
Related Documents :
6172585 - A comparison of serial quantitative serum and urine tests in early pregnancy.
8595125 - Anticardiolipin antibodies in patients with pregnancy loss induce factor xa production ...
6476035 - A contemporary approach to suspected ectopic pregnancy with use of quantitative and qua...
3454505 - Human chorionic gonadotropin regression following removal of ectopic pregnancy.
7468105 - Study of a new intrauterine device, the multiload 250 cu.
6493655 - Continuing role of the nonstress test in the management of postdates pregnancy.
Publication Detail:
Type:  Journal Article     Date:  2009-12-03
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  202     ISSN:  1097-6868     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-01     Completed Date:  2010-02-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  139.e1-6     Citation Subset:  AIM; IM    
Copyright Information:
Copyright 2010 Mosby, Inc. All rights reserved.
Affiliation:
Department of Obstetrics and Gynecology, Eastern Virginia Medical School, CONRAD Clinical Research Center, 601 Colley Ave., Norfolk, VA 23507, USA. thurmaar@evms.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Chorionic Gonadotropin, beta Subunit, Human / blood*
Female
Humans
Logistic Models
Methotrexate / administration & dosage*
Pregnancy
Pregnancy, Ectopic / blood,  drug therapy*
Chemical
Reg. No./Substance:
0/Chorionic Gonadotropin, beta Subunit, Human; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Caring for the pregnant woman presenting at periviable gestation: acknowledging the ambiguity and un...
Next Document:  Increased calcium and decreased magnesium and citrate concentrations of submandibular/sublingual sal...